309
Views
36
CrossRef citations to date
0
Altmetric
Research Article

Physicochemical Characterization and Dissolution Study of Solid Dispersions of Lovastatin with Polyethylene Glycol 4000 and Polyvinylpyrrolidone K30

&
Pages 21-33 | Received 21 Aug 2006, Accepted 05 Sep 2006, Published online: 07 Oct 2008

REFERENCES

  • Chiou W.L., Riegalman S. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 1971; 60: 1281–1302
  • Serajuddin A.T.M. Solid dispersions of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J. Pharma. Sci. 1999; 88: 1058–1066
  • Leuner C., Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 2000; 50: 47–60
  • Sekiguchi K., Obi N. Studies on absorption of eutectic mixtures. I. A comparison of the behaviour of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem. Pharm. Bull. 1961; 9: 866–872
  • Margarit M.V., Rodri´guez I.C., Cerezo A. Physical characteristics and dissolution kinetics of solid dispersions of ketoprofen and polyethylene glycol 6000. Int. J. Pharm. 1994; 108: 101–107
  • Mura P., Faucci M.T., Manderioli A., Bramanti G., Parrini P. Thermal behavior and dissolution properties of naproxen from binary and ternary solid dispersions. Drug Dev. Ind. Pharm. 1999; 25: 257–264
  • El-Gazayerly O.N. Characterization and evaluation of tenoxicam coprecipitates. Drug Dev. Ind. Pharm. 2000; 26: 925–930
  • Ryh-Nam P., Jing-Huey C., Russel R.C. Enhancement of dissolution and bioavailability of piroxicam in solid dispersions systems. Drug Dev. Ind. Pharm. 2000; 26: 989–994
  • Craig D.Q.M. The mechanism of drug release from solid dispersion in water-soluble polymers. Int. J. Pharm. 2002; 231: 131–144
  • Taylor L.S., Zografi G. Spectroscopic characterization interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm. Res. 1997; 14: 1691–1698
  • Yamashita K., Nakate T., Okimoto K., Ohike A., Tokunaga Y., Ibuki R., Higaki K., Kimura T. Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int. J. Pharm. 2003; 267: 79–91
  • Susumu H., Takeshi H., Naho F., Akira K., Etsuo Y., Katsuhide T. Effects of water content in physical mixture and heating temperature on crystallinity of troglitazone-PVP K30 solid dispersions prepared by closed melting method. Int. J. Pharm. 2005; 302: 103–112
  • Teresa M. M., Victoria M. M., Gloria E. S. Characterization and solubility study of solid dispersions of flunarizine and polyvinylpyrrolidone. Il Farmaco. 2002; 57: 723–727
  • Franco M., Trapani G., Latrofa A., Tullio C., Provenzano M.R., Serra M., Muggironi M., Biggio G., Liso G. Dissolution properties and anticonvulsant activity of phenytoin-polyethylene glycol 6000 and -polyvinylpyrrolidone K-30 solid dispersions. Int. J. Pharm. 2001; 225: 63–73
  • Van den Mooter G., Augustijns P., Blaton N., Kinget R. Physicochemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int. J. Pharm. 1998; 164: 67–80
  • Melgardt M.V., Dale E.W., Jakkie G., Amol K. X-ray powder diffraction determination of the relative amount of crystalline acetaminophen in solid dispersions with PVP. Int. J. Pharm. 1998; 163: 219–224
  • Arias M.J., Moyano J.R., Gines J.M. Study by DSC and HSM of the oxazepam PEG 6000 and oxazepam-D-mannitol systems: application to the preparation of solid dispersions. Thermochimica Acta. 1998; 321: 33–41
  • MacDonald J.S., Gerson R.J., Kornburst D.J., Kloss M.W., Prahalada S., Berry P.H., Alberts A.W., Bokelman D.L. Preclinical evaluation of lovastatin. Am. J. Cardiol. 1998; 62(15)16J–27J, Review
  • Slater E.E., MacDonald J.S. Mechanism of action and biological profile of HMG CoA reductase inhibitors: A new therapeutic alternative. Drugs. 1998; 36(Suppl. 3)72–82
  • Gerald S.B., Dean K.E., Micheal J.K. G.B. HarryLovastatin. Analytical Profiles of Drug Substances and Excipients, . Academic press, Inc, New York 1992; 21: 277–315
  • Frances C., Veiga M.D., Espanol O.M., Cadorniga R. Preparation, characterization and dissolution of ciprofloxacin/PEG 6000 binary systems. Int. J. Pharm. 1991; 77: 193–198
  • Christian L., Jennifer D. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 2000; 50: 47–60
  • Moore J.W., Flanner H. Mathematical comparison of dissolution profiles. Pharm. Technol. 1996; 20(6)64–74
  • Barzegar-Jalali M., Maleki N., Garjani A., Khandar A.A., Haji-Hosseinloo M., Jabbari R.C, Dasmalchi S. Enhancement of dissolution rate and anti-inflammatory effects of piroxicam using solvent deposition technique. Drug Dev. Ind. Pharm. 2002; 28: 681–686
  • Tang L., Khan S.U., Muhmmad N.A. Evaluation and selection of bio-relevant dissolution media for a poorly water soluble new chemical entity. Pharm. Dev. Technol. 2001; 6: 531–540
  • Reppas C., Nicolaides E. J.B. Dressman, H. Lennernäs“Analysis of drug dissolution data'. Oral Drug Absorption Prediction and Assessment, . Marcel Dekker, Inc, New York 2000; 229–254
  • Vueba M.L., Batista de Carvalho L.A.E., Veiga F., Sousa J.J., Pina M.E. Influence of cellulose ether polymers on ketoprofen release from hydrophilic matrix tablets. Eur. J. Pharm. Biopharm. 2004; 58: 51–59
  • Aulton M.E. Pharmaceutical Technology. Pharmaceutics: The Science of Dosage Form Design. Churchill Livingstone, London 1988; 600–616

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.